LEXICON PHARMACEUTICALS, INC. Finance Lease, Weighted Average Discount Rate, Percent
LEXICON PHARMACEUTICALS, INC. (LXRX) had Finance Lease, Weighted Average Discount Rate, Percent of 0.096 Rate as of 2023-06-30, per its 10-Q filed 2023-08-04.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2023-08-04
- 2022-12-31: Finance Lease, Weighted Average Discount Rate, Percent 9.60%.
- 2021-12-31: Finance Lease, Weighted Average Discount Rate, Percent 9.00%.
pure
| Period end | Finance Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2022-12-31 | 9.60% 10-K · filed 2023-03-03 |
| 2021-12-31 | 9.00% 10-K · filed 2023-03-03 |
Rate
| Period end | Finance Lease, Weighted Average Discount Rate, Percent | Finance Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2023-06-30 | 0.10 Rate 10-Q · filed 2023-08-04 | |
| 2023-03-31 | 9.60 Rate 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 0.10 Rate 10-Q · filed 2023-08-04 | 9.60 Rate 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |